Radiofrequency Ablation Devices Market Worth USD 6.7 Billion By 2026 Growing At A CAGR Of 11.6% | Grand View Research, Inc.

Radiofrequency Ablation Devices Market Worth USD 6.7 Billion By 2026 Growing At A CAGR Of 11.6% | Grand View Research, Inc.

“”Grand View Research, Inc. – Market Research And Consulting.””
According to a new report published by Grand View Research, market is majorly driven by the growing prevalence of chronic and cardiovascular diseases and preference for minimally invasive surgeries.

The global radiofrequency ablation devices market size is anticipated to reach USD 6.7 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to register a CAGR of 11.6% during the forecast period. Increasing preference for minimally invasive surgeries, growing geriatric population, and rise in healthcare spending for better disease treatment are expected to propel the growth.

According to the American Society of Plastic Surgeons, by the end of 2015, 15.9 million minimally invasive cosmetic surgeries were performed in U.S. According to the Centers for Disease Control and Prevention (CDC), more than six million laparoscopic procedures are performed across the U.S. and EU countries every year.

Radiofrequency ablation is now used early in the management of patients suffering from atrial tachycardia or atrial fibrillation or other kinds of coronary disease. This factor is anticipated to boost the market growth. According to the American College of Cardiology Foundation, coronary heart disease is the leading cause of deaths (43.8%) in U.S., followed by stroke (16.8%), heart failure (9.0%), high BP (9.4%), and other CVDs (17.9%). By 2035, the total cost of CVD is expected to reach USD 1.1 trillion and is projected to affect 45.1% (130 million) adults in U.S.

Radiofrequency ablation can also be used to reduce neck pain, low-back pain, arthritis, and pelvic and peripheral nerve pain. According to WebMD LLC., RFA has been proven to be effective in more than 70% of the patients experiencing pain. Pain relief from RFA can last from six to 12 months or even a year. 

Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market

Radiofrequency Ablation Devices Market Report Highlights

 Disposable equipment held the largest market share in 2018 due to reduced morbidity and mortality and the ability of the equipment to provide treatment in an outpatient setting. For example, Radiopaque RF cannula (Halyard Worldwide, Inc) provides improved visualization under fluoroscopy for accurate positioning, resulting in a targeted treatment

Cardiology and cardiac rhythm management is anticipated to be the fastest-growing segment during the forecast period due to disease prevalence, growing awareness, and adoption of minimally invasive operations. In 2012 RFA-Academia launched an initiative to increase awareness in Europe and to teach endoscopists safe and justified application of RFA to reduce the disease burden

North America is anticipated to continue leading the radiofrequency ablation devices market during the forecast period due to high healthcare expenditure, incidence of cardiac disease and cancer, and the number of patients suffering from pain.

Asia Pacific is expected to witness significant growth over the next decade due to increasing demand for minimally invasive procedures to treat cancer and growing awareness regarding the benefits of ablation method over the conventional surgical procedures.

Some of the key players are Boston Scientific Corporation; Medtronic; Stryker; Cosman Medical, Inc.; St. Jude Medical; Smith & Nephew; Johnson & Johnson (J&J) Services, LLC; and AngioDynamics.

For Requesting a Sample Copy Please Visit @ https://www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market/request/rs15

Radiofrequency Ablation Devices Market Segmentation

Grand View Research has segmented the global radiofrequency ablation devices market based on type and region:

Radiofrequency Ablation Devices Product Outlook (Revenue, USD Million, 2015 – 2026)
    • Disposable Equipment
    • Capital Equipment
    • Reusable Equipment

Radiofrequency Ablation Devices Mode of Delivery Outlook (Revenue, USD Million, 2015 – 2026)
    • Surgical Oncology
    • Cardiology & Cardiac Rhythm Management
    • Cosmetology
    • Gynecology
    • Pain Management

Radiofrequency Ablation Devices Regional Outlook (Revenue, USD Million, 2015 – 2026)
     North America
        • The U.S.
        • Canada
    • Europe
        • Germany
        • The U.K.
        • Spain
        • Italy
        • France
    • Asia Pacific
        • China
        • India
        • Japan
    • Central and South America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa

Fill The Pre-Order Enquiry Form For The Report @ https://www.grandviewresearch.com/inquiry/463/ibb

 

About Grand View Research

Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market